POZ.com POZ Personals POZ Mentor POZ ASO Directory AIDSmeds Real Health TuSalud ComboCards Rx Info Cards
Diary of a Doc: Vaccine Update at ICAAC
ICAAC: Trizivir vs. Reyataz/Combivir
ICAAC: Norvir-Boosted Lexiva vs. Reyataz
Predictive Value of Viral Load Testing Questioned
ICAAC: MK-0518 Potent for Treatment Experienced
ICAAC: More Drug-Resistant HIV?
ICAAC: Prezista and Aptivus on Drug-Resistant HIV
Prezista Women's Study Opens for Enrollment
ICAAC Opens in San Francisco
ICAAC: Predicting Responses to Aptivus or Prezista
ICAAC: MK-0518 Appears Lipid Friendly
ICAAC: Abortion Pill for HIV? Questions Still Remain